Know Cancer

or
forgot password

The Effect of Human Placental Explants and Pregnant Women Sera on Cancer Cells


N/A
18 Years
45 Years
Not Enrolling
Female
Cancer

Thank you

Trial Information

The Effect of Human Placental Explants and Pregnant Women Sera on Cancer Cells


In the Oncogenetic laboratory cancer cells will be exposed to first trimester human
placental explants or to serum collected from pregnant women. As a control cancer cells will
be cultured alone or in the presence of sera collected from young (18-45) non pregnant
women.

Placentae, 6-9 weeks gestational age, will be retrieved from terminated normal pregnancies.
The placenta will be taken after pregnancy termination, thus, no harm will be caused for the
women.

The sera will be collected from the women by an authorized physician. It will be taken from:
1. the vein of the non pregnant women and volunteered pregnant women. 2. from the same
branula that will be introduced into the pregnant women as a routine during pregnancy
termination procedure.

Following culture we will analyze the cancer cells phenotype (cell death, proliferation,
migration, and invasion), signaling pathway, mRNA, miRNA and protein expression.

Sera will be collected from 50 pregnant women and 50 non pregnant women. Placentae will be
collected from 50 pregnant women.


Inclusion Criteria:



- Healthy women

- Age 18-45.

- Pregnant (6-9 weeks) and non pregnant women.

Exclusion Criteria:

• Placentae that were destroyed during pregnancy termination.

Type of Study:

Observational

Study Design:

N/A

Outcome Measure:

Cancer cell phenotype (in the laboratory)

Outcome Description:

Changes in: cell death (% from tested cells) cell cycle (% cells in G1, G2 and S phases) cell migration (% closure in Scratch test) cell invasion (% cells passing through membrane in Transwell assay) RNA repertoire (Fold change) miRNA repertoire (Fold change)

Outcome Time Frame:

Week

Safety Issue:

No

Principal Investigator

Michael Lishner, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Meor Medical Center, Kfar-Saba, Israel

Authority:

Israel: Ministry of Health

Study ID:

0053-13-MMC

NCT ID:

NCT01879436

Start Date:

July 2013

Completion Date:

July 2014

Related Keywords:

  • Cancer
  • Pregnancy, Placenta, Cancer

Name

Location